top of page
Incretin Mimetics in Cardiometabolic Disease: How Far Can They Go in Addressing Residual Risk?
Join us on June 22 at 2:00 p.m. GMT
Incretin Mimetics in Cardiometabolic Disease: How Far Can They Go in Addressing Residual Risk?
bottom of page